In a successful operation yesterday at the Royal Brompton Hospital in London, the 50th patient received their ExoVasc Personalised External Aortic Root support. For surgeon
As debate in the medical press continues on the likely mechanism of action and efficacy of drugs that might slow or protect against aortic dilatation
Tal Golesworthy has just been awarded one of the first six Patient Innovation Awards. In a statement, the Patient Innovation Advisory Board said, “The Patient
A paper by Tom Treasure and John Pepper called Personalised External Aortic Root Support (PEARS) Compared with Alternatives for People with Life-Threatening Genetically Determined Aneurysms
We develop medical devices that manage aortic dilation and minimise the risk of aortic dissection.